High Tech Pharm Co. Ltd
High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.
High Tech Pharm Co. Ltd (106190) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.052x
Based on the latest financial reports, High Tech Pharm Co. Ltd (106190) has a cash flow conversion efficiency ratio of 0.052x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩6.60 Billion) by net assets (₩126.99 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
High Tech Pharm Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how High Tech Pharm Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
High Tech Pharm Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of High Tech Pharm Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NNIT A/S
LSE:0R5Z
|
0.044x |
|
The Hain Celestial Group Inc
NASDAQ:HAIN
|
0.112x |
|
Media Nusantara Citra Tbk PT
JK:MNCN
|
0.008x |
|
flooidCX Corp
PINK:FLCX
|
0.270x |
|
BIOINVENT INTERN. SK 2
F:BIX0
|
N/A |
|
Lincoln Pharmaceuticals Limited
NSE:LINCOLN
|
0.070x |
|
Cox Energy América, S.A.B. de C.V.
MC:COXE
|
0.175x |
|
Wieson Technologies Co Ltd
TWO:6272
|
0.046x |
Annual Cash Flow Conversion Efficiency for High Tech Pharm Co. Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of High Tech Pharm Co. Ltd from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩119.74 Billion | ₩14.69 Billion | 0.123x | +351.33% |
| 2023-12-31 | ₩106.99 Billion | ₩2.91 Billion | 0.027x | +173.37% |
| 2022-12-31 | ₩99.94 Billion | ₩-3.70 Billion | -0.037x | -150.21% |
| 2021-12-31 | ₩93.88 Billion | ₩6.93 Billion | 0.074x | +191.29% |
| 2020-12-31 | ₩95.14 Billion | ₩-7.69 Billion | -0.081x | -420.83% |
| 2019-12-31 | ₩98.58 Billion | ₩2.48 Billion | 0.025x | -51.59% |
| 2018-12-31 | ₩103.35 Billion | ₩5.38 Billion | 0.052x | -2.44% |
| 2017-12-31 | ₩102.19 Billion | ₩5.45 Billion | 0.053x | +272.82% |
| 2016-12-31 | ₩101.18 Billion | ₩1.45 Billion | 0.014x | -89.06% |
| 2015-12-31 | ₩97.20 Billion | ₩12.71 Billion | 0.131x | +18.32% |
| 2014-12-31 | ₩92.06 Billion | ₩10.17 Billion | 0.110x | -- |